This is your blog intro text.
The ongoing response to the COVID-19 pandemic has highlighted the critical role of the North Carolina life sciences industry in battling our most serious public health threats. When faced with the threat of COVID-19, biotechnology companies — many based right here in North Carolina —... Continue Reading
This post originally appeared on the website of the Environmental Paper Network. A serious approach to addressing climate change must include the proactive elimination of unnecessary paper consumption. Paper is an important and useful material that should be produced and consumed in a... Continue Reading
Michelle McMurry-Heath, M.D., Ph.D., president and CEO of the Biotechnology Innovation Organization, released the following statement after the House of Representatives passed the Build Back Better Act on Nov. 19: “The legislation that passed the House today will upend a successful Medicare... Continue Reading
Representatives from the NC Community Colleges’ BioNetwork, the NC Pharmaceutical Services Network, BRITE at NC Central University, NC A&T University and North Carolina State University’s BTEC were all on hand Tuesday, Nov. 16, at the NCBIO Biotech Manufacturers Forum Meeting to... Continue Reading
Jude Samulski, Ph.D., told NCBIO Annual Meeting attendees that the field of gene therapy is the beginning of something that will transform lives forever. Therapies created today for rare diseases will tomorrow generate treatments for common ills like high cholesterol, diabetes and heart failure,... Continue Reading
NCBIO and the N.C. Community College System announced the recipients of the newly established Samuel M. Taylor Memorial Life Sciences Scholarship. The Samuel M. Taylor Scholarship was established at the North Carolina Community Colleges Foundation Inc. in memory of Sam Taylor, a founder and... Continue Reading
During a busy week in Congress, Democrats included a change to the Orphan Drug Tax Credit that would negatively impact research on rare diseases affecting millions of Americans. The U.S. House of Representatives has several committees marking up the Senate’s $3.5 trillion budget... Continue Reading
The summer calm is grinding to a halt as members of Congress have returned to D.C. for what is sure to be a busy legislative sprint that could potentially impact all sectors of the biotech industry. The State of Play The House adjourned two weeks ago after laying the groundwork (on a party-line... Continue Reading
Rep. Donna McDowell White welcomes attendees NCBIO President Laura Gunter Scott Uknes, Ph.D., co-founder and co-CEO of AgBiome John Fleming, a farmer and partner with Fleming Brothers Farms, LLC in Halifax Sinnovatek President and CEO Michael Druga T. Y. Baker and... Continue Reading
NC Secretary of Commerce Machelle Sanders North Carolina Secretary of Commerce Machelle Baker Sanders encouraged the life sciences industry to be an active participant in shaping the state’s economic plan during the quarterly meeting of the NCBIO Biotech Manufacturer’s Forum held... Continue Reading
BIO: Where things stand with TRIPS waiver It’s been a while since we’ve talked about what’s going on at the WTO. Here’s the latest news—and why the proposed waiver of vaccine IP is still a bad idea. The status: The World Trade Organization is still... Continue Reading
Representatives from G1 Therapeutics, United Therapeutics and Thermo Fisher Scientific shared insights from their companies with members of the North Carolina General Assembly's Life Science Caucus on during its meeting held Wednesday, July 21. Caucus co-chairs Sen. Mike Woodard, Sen.... Continue Reading
